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Abstract. PECAM-1 is a 130-120-kD integral mem-
brane glycoprotein found on the surface ofplatelets, at
endothelial intercellular junctions in culture, and on
cells of myeloid lineage. Previous studies have shown
that it is a member ofthe immunoglobulin gene super-
family and that antibodies against the bovine form of
this protein (endoCAM) can inhibit endothelial
cell-cell interactions. These data suggest that
PECAM-1 may function as a vascular cell adhesion
molecule. The function of this molecule has been fur-
ther evaluated by transfecting cells with a full-length
PECAM-1 cDNA. Transfected COS-7, mouse 3T3 and
L cells expressed a 130-12041) glycoprotein on their
cell surface that reacted with anti-PECAM-1 poly-
ELL-CELL interactions are mediated by at least four
distinct families of transmembrane glycoproteins:
inte 'ns, cadherins selectins Lec-CAMS ' and
cell adhesion molecules belonging to the immunoglobulin
superfamily (reviewed in Albelda and Buck, 1990). The
integrin family is a broadly distributed group of receptors
composed ofhomologous, noncovalently associated a/ß het-
erodimer pairs that mediate leukocyte-leukocyte and leuko-
cyte-endothelial cell adhesion (Carlos and Harlan, 1990;
Osborn, 1990; Springer, 1990), as well as cellular interac-
tionswithextracellularmatrix components suchascollagen,
laminin, fibrinogen, and fibronectin (Buck and Horwitz,
1987; Ruoslahti and Piersbacher, 1987; Hynes, 1987). The
cadherin family is a developmentally regulated group of
structurally related, single chain 120-13041) glycoproteins
thatmediatecalcium-dependent cellularadhesion inahomo-
philic and tissue-specific manner (Takeichi, 1988, 1991).
The selectins or Lec-CAMS (including ELAM-1, GMP-140,
and gp90MEL-1°) bind leukocytes to endothelial cells via a
lectin-like domain at the amino terminus of the molecule
(Bevilacquaetal., 1989; Johnston etal., 1989; Larsen etal.,
1989; Butcher etal., 1990; Imai etal., 1990; Bradley etal .,
1990).
1. Abbreviations used in this paper: LecCAM, selectin cell adhesion mole-
cule; PECAM, platelet/endothelial cell adhesion molecule.
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clonal and monoclonal antibodies. COS-7 and 3T3 cell
transfectants formed cell-cell junctions that were
highly enriched in PECAM-1, reminiscent of its distri-
bution at endothelial cell-cell borders. In contrast, this
protein remained diffusely distributed within the
plasma membrane of PECAM-1 transfected cells that
were in contact with mock transfectants. Mouse L
cells stably transfected with PECAM-1 demonstrated
calcium-dependent aggregation that was inhibited by
anti-PECAM antibodies. These results demonstrate
that PECAM-1 mediates cell-cell adhesion and support
the idea that it may be involved in some of the inter-
active events taking place during thrombosis, wound
healing, and angiogenesis.
The cell adhesion molecules (CAMS) belonging to the
immunoglobulin gene (Ig) superfamily show diversity in
function and tissue distribution. Like other members of the
Ig-superfamily, CAMS share acommonstructure, the immu-
noglobulinhomology unit, thatis characterized by anamino
acid sequence -100 amino acids in length, having a cen-
trally placed disulfide bridge that stabilizes a series ofanti-
parallelß-strands intothe so-calledantibody fold (Hunkapil-
ler and Hood, 1989). The immunoglobulin superfamily
CAMS are thought tohave wide-ranging functions, and par-
ticipate in a variety ofhomophilic and heterophilic cellular
interactions (Williams and Barclay, 1988), including those
thattake placeduring development(N-CAM) (Cunningham
etal., 1987; Edelman, 1988), inflammationand woundheal-
ing (ICAM-1, VCAM-1) (Wawryk et al., 1989; Elices etal.,
1990), and possibly oncogenesis (CEA: colon carcinoma
cell metastasis) (Benchimol et al., 1989).
PECAM-1 (platelet/endothelial cell adhesion molecule-1)
represents arecently characterizedmember ofthe immuno-
globulin superfamilythatis foundonthesurfaceofplatelets,
some leukocytes and at endothelial cell intercellular junc-
tions inculture (Muller et al., 1989; Newman etal., 1990).
Ahomologous glycoprotein, "endothelial cell adhesion mol-
ecule7 (endoCAM) hasbeendescribedonbovine endothelial
cellsandplateletsandhasbeenshowntomediateendothelialcell-cell interactions (Albelda et al., 1990). Immunochemi-
cal and biochemical studies (Albelda et al., 1990; Newman
et al ., 1990) indicate that PECAM-1 is identical to the hec7
and CD31 antigens that have been described on humanblood
platelets,monocytes, and neutrophils, as well as on large and
small vessel endothelial cells (Muller et al., 1989; van
Mourik et al., 1985 ; Stockingeret al., 1990). Bone marrow
stem cells and transformed cell lines of the myeloid and
megakaryocytic lineage also express CD31 (Ohio et al .,
1985 ; Goyert et al., 1986; Cabanas et al., 1989; Simmons
et al., 1990).
Although the precise functions of PECAM-1 (CD31) have
not been determined, we have shown (a) that PECAM-1 is
concentrated on cultured endothelial cells at intercellular
junctions as they come to appose one another (Muller et al.,
1989; Albelda et al., 1990); (b) that PECAM-1 is constitu-
tively expressed on continuous, but not sinusoidal, en-
dothelium in situ (Muller et al., 1989 ; Albelda et al., 1990) ;
and (c) that antibodies against endoCAM, the bovine equiva-
lent of PECAM-1, inhibit the ability of endothelial cells to
form a confluent monolayer (Albelda et al., 1990). These
data indicate that this molecule is involved in endothelial
cell-cell adhesion.
The homology ofPECAM-1 to other CAMs of the immu-
noglobulinsuperfamily, its presence on platelets, whitecells,
and endothelium, its localization to endothelial cell junc-
tions, and the initial functional data described above, all sug-
gest that PECAM-1 is an important vascular cell adhesion
molecule. In this manuscript, we present the full-length
cDNA sequence, describe the expression of PECAM-1 in
heterologous COS-7, 3T3, and L cells, and demonstrate that
PECAM-1 is capable of mediating the aggregation of stably
transfected mouse L cells. These experiments directly dem-
onstrate the role of PECAM-1 in adhesion events.
Materials andMethods
Antibodies
The following antibodies were used: hec7 and WM59, mAbs specific for
human PECAM-1 (Muller et al., 1989; Newman et al., 1990); a poly-
clonal antibody directed against bovine endoCAM that cross reacts with hu-
man PECAM-1 (Albelda et al., 1990); an anti-CD31 monoclonal anti-
body generously provided by Jan Sixma (University Hospital, Utrecht, the
Netherlands); a polyclonal anti-human PECAM-1 antibody; and an antise-
rumto von Willebrand factor (vWF) (Calbiochem-Behring Diagnostics, La
Jolla, CA). FITC-conjugated anti-mouse and anti-rabbit antisera were pur-
chased from Organon Technika Corp (West Chester, PA) .
The polyclonal anti-PECAM antiserum was produced using the same
techniques as were used to prepare an anti-endoCAM antiserum (Albelda
et al., 1990). PECAM-1 was purified from outdated human platelets by
affinity chromatography using the anti-PECAM mAb 1.3 (IgGI subclass)
and 100-pg aliquots ofpurifiedprotein were injected into a rabbit in combi-
nation with Freund's adjuvent at2-wk intervals for atotal offour injections.
Purified immunoglobulinwas isolatedby protein A (Pharmacia Fine Chem-
icals, Piscataway, NJ) affinity chromatography. The specificity ofthe poly-
clonal antiserum was equivalent to that of the monoclonal antibodies (see
below) .
Cells
Human umbilical vein endothelial cells were isolated and cultured in
medium 199 containing 15% FBS, 75-100 pg/ml endothelial cell growth fac-
tor, 100 pg/ml heparin, and2 mM t,-glutamine (Albeldaet al., 1989). COS-
7, 3T3 cells, and mouse L cells were purchased from the American Type
Culture Collection (ATCC, Rockville, MD). COS-7 cells and 3T3 cells were
cultured in DMEM with 10% FBS. L cells were cultured in RPMI medium
with 10% FBS.
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Nucleotide Sequencing
The complete nucleotide sequenceofPECAM-1 was determined from three
overlapping Xgt11 phage clones (Newman et al., 1990). A series ofoverlap-
ping nested deletions were generated using exonuclease III. After this diges-
tion, the remaining single-stranded material was cleaved with Sl nuclease,
the ends made blunt with T4 DNA polymerase, and the plasmids resealed
with T4 DNA ligase. Both strands ofall overlappingclones were sequenced
by the didioxy-chaintermination methodusing Sequenase DNA polymerase
(United States Biochemical Co., Cleveland, OH) .
NorthernBlotAnalysis
Total cellular RNA was prepared from both human umbilical vein en-
dothelial cells and HEL cells using the method of Chirgwin et al. (1979)
and the poly (A+) fractionpurified on Oligo d(T) cellulose according to the
procedure ofAvril and Leder (1972). 15 pg oftotal RNA or 3 pg ofmRNA
was denatured in 1 M glyoxal in the presence of 50% DMSO, electropho-
resed through 1% agarose, and transferredto nitrocellulose according to the
procedure ofThomas (1980). Both prehybridization and hybridization were
performed at 42°C in a buffer containing 40% formamide, 4x SSC
(SSC=0.15 M NaCl, 15 mM trisodium citrate, pH 7.0), 7 mM Tris pH 7.4,
lx Denhardt's solution, and 50 pg/ml of salmon sperm DNA. Filters were
washed at high stringency, with the final two washes performed at 68°C in
0.1 % SSC containing 1.0% SDS. Northern blots were also performed using
Genescreen Plus (Dupont New England Nuclear, Wilmington, DE) accord-
ing to the manufacturer's directions.
Ransfection ofCOS-7 Cells
A 2.56-kb cDNA fragment containing the entire coding sequence for
PECAM-1 was subcloned from PEGEM 7Z (Promega Biotec, Madison,
WI) into the Hind1II cloning site of the SV40 expression vector pESP-
SVTEXP (Reddy andRao, 1986; Solowska et al., 1989). The resulting plas-
mid was designated PECAM/TEX. COS cell transfections were performed
by calcium phosphate-DNA coprecipitation (Sambrook et al., 1989).
Confluent T75 flasks of COS-7 cells were split 1:15 and plated on 100-mm
petri dishes inDMEM with 10% FBS. After 24 h, the cells weretransfected
with 6 pg PECAM/TEX cDNA in combination with 17 pg of Bluescript
plasmid DNA (Stratagene Corp., La Jolla, CA) . After incubation at 37°C
for 4 h, the cells were washed with PBS, and fresh DMEM/10% FBS was
added. The plates were maintained foran additional 36 h before extraction
or immunofluorescence staining.
Tlransfection of373 andLCells
To establish cells stably expressing PECAM-1 cDNA, NIH 3T3 cells were
transfected as previously described (Solowska et al., 1989). Cells were
plated at 1 x 105 per 100-mm petri dish in DMEM with 10% FBS. After
24 h, the cells were cotransfected with 6 jig of the PECAM/TEX plasmid
in combination with 100 ng pSV2neo and 17 pg calfthymus DNA as a cal-
cium phosphate precipitate. Cells were incubated for 20-22 h, washed with
PBS, and fresh medium was replaced. 2 d later, the transfected cells were
split 1:25 to 1:50 and incubated in DMEM supplemented with 10% FBS
and 1 mg/ml G418 (Geneticin; Gibco Laboratories, GrandJsland, NY). Af-
ter -2 wk, the G418-resistant clones were isolated and expanded. The 3T3
clones expressing PECAM-1 were identified by indirect immunofluores-
cence staining using the PECAM-1 specific mAb hell. The most positively
staining clones were then subcloned by limiting dilution and a cell line ex-
pressing PECAM-1 on -80-90% cells was used for further studies.
Mouse L cells were transfected in a similar manneras the 3T3 cells with
the following changes: (a) the pH of the transfection buffer was adjusted to
6.95 rather than 7.2; (b) cells were plated at 5 x 105 per 100 mm petri
dish; and (c) clones were selected in RPMI media supplemented with 10%
FBS and 0.5 mg/ml G418. Afterselectionby immunofluorescence, the most
positive clones were further characterized by FACS analysis (see below)
using the and-PECAM mAb hec7.
FlowCytometry
Lcells transfected withpSV2neo alone or PECAM/TEX were nonenzymat-
ically removed from 125 flasks (see below), washed in PBS/4% BSA, and
treated with anti-PECAM-1 mAb for 1 h at4°C. The primary antibody was
removed, the cells washed twice with ice-cold PBS, and a 1:200 dilution
of FITC-labeled goat anti-mouse secondary antibody added for 1 hat 4°C.
After washing in cold PBS, flow cytometry was performed using an Ortho
1060Cytofluorograph 50H cell sorter equipped with a 2150 Data Handling Sys-
tem (Ortho Instruments, Westwood, MA). Fluorescence intensity was ex-
pressed as arbitrary units on a log scale.
CellLabeling
lb metabolically label cultured cells, confluent flasks were washed with
PBS, incubated in methionine-free DMEM supplemented with 10% dia-
lyzed FBS for 1 h, and then labeled with 135Slmethionine (New England
Nuclear, Boston, MA) (200 uCi for 25 cm2, 300 ACi for 75-cm2 flasks)
in fresh medium. For labeling of human endothelial cells, the methionine-
free DMEM/10% FBS was supplemented with endothelial cell growth fac-
tor and heparin as described (Albelda et al., 1989). After 24 h, the cells
were washed with PBS and extracted as described below.
Cultured cells were surface labeled with "I using previously described
techniques (Albelda et al., 1989). Briefly, transfected COS cells were
washed three times with PBS and exposed to carrier free "I (1 mCi/100-
mmplate) inthe presence oflactoperoxidase, glucoseoxidase, and glucose.
After labeling for 30 min, the reaction was terminated by the addition of
free iodine and the cells were extracted. Membrane extracts were prepared
by adding small amounts (i.e., two orthree times the volume ofthe cell pel-
let) of TNC (0.01 M Tris acetate, pH 8.0, 0.5% NP-40, 0.5 mM CaC12)
with 2 mM PMSF to the pellet, pipettint on ice for 15 min, and then cen-
trifuging for 30 min at 12,000 g. The resulting supernatant was used im-
mediately or frozen at -20°C until used.
Immunoprecipitation
Nonionic detergent extracts were preadsorbed for 30 min at 4°C with Pro-
tein A conjugated to Sepharose beads (Pharmacia Fine Chemicals). After
removal ofthe beads, the appropriate antibody was added to the precleared
extract for 1 h at 4°C. Immunocomplexes were collected by precipitation
with fresh Protein A-sepharose beads for 1 h at 4°C, washed fivetimes with
a buffer containing 50 mM Tris HCl (pH Z5), 150 mM NaCl, 1% Triton
X-100, 5 % deoxycholate, and 0.1% SDS. The sample was then dissolved in
electrophoresis samplebuffer (62 .5 mM Tris base, 2% SDS, 10% glycerol,
pH 6.8), electrophoresed on 6% polyacrylamide gels and processed for au-
toradiography as described below.
One-Dimensional GelElectrophoresis
Samples were analyzed by SDS-PAGE using 6% polyacrylamidegels by the
method of Laemmli (1970) without the use of reducing agents. Gels were
dried and exposed to Kodak XR5 X-ray film at -70°C.
Immunofluorescence
Endothelial cells were plated at 4 x 10° cells/cm2 on glass coverslips
coated with 1% gelatin in PBS (Difco, Detroit, MI) . After the cells had
grown to confluence, fixation and staining was performed using previously
described methods (Albeldaet al., 1989). Briefly, cells were fixed with 3 %
paraformaldehyde for 20 min and then permeabilized with ice-cold 0.5%
NP-40 for 1 min. After extensive washing, 50 pl of antibody was added for
1 h. After rinsing, the coverslips were stained with 50 pl ofa 1:200dilution
ofFITC-labeled antimouse antibodies for 1 h. Cells were viewed on a Zeiss
phase-epifluorescent microscope using a 63x planapochromat oil-immer-
sion lens numerical aperature 1.4 and photographed using Tri-X film at
400 ASA.
COS-7 cells were plated on gelatin-coated glass coverslips placed in six-
well plates. 1 d after plating, the cells were transfected with PECAM-1. 48
h after transfection, the cells werefixed, stained, and analyzed as described
above.
For coculture experiments, equal numbersof endothelial cells and trans-
fected 3T3 cells were mixed and plated together to acheive a final cell den-
sity of 2 x 10° cells/cm2 on glass coverslips that had been coated with 10
pg/ml of purified plasma fibronectin (New York Blood Center, New York,
NY) for 1 h. After overnight incubationinendothelial cell medium, the cov-
erslips were fixed, permeabilized, and stained with both anti-PECAM-1
mAb (hec7) and rabbit anti-vWF antiserum. After washing, the cells were
treated with fluorescein-conjugated anti-mouse antibody and rhodamine-
conjugated anti-rabbit antibody. Control experiments demonstrated no
cross-species reactivity between the second antibody reagents.
Aggregation ofL Cell Tlransfectants
A variation of the aggregation assay of Takeichi (1977) established for the
study of cells expressing cadherin molecules was developed. Stable L cell
transfectants were washed twice in HBSS without divalent cations and then
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incubated for 10-20 min at 37°C in 5 mM EGTA in HBSS, pH 7.4. When
inverted phase-contrast microscopy showed that the cells had visibly
rounded and begun to detach, they were removed from the dish by gentle
pipetting. The cells were washed twice in coldHBSS. In some experiments,
cells were incubated with 25 lag/ml of purified anti-PECAM-1 polyclonal
antibodies ornonimmune rabbit IgG atthis point. Inthese experiments cells
were then resuspended to -106 cells/ml and incubated with antibodies on
ice for 20 min. Cells were subsequently washed twice in cold HBSS to re-
move unbound antibody and resuspended to -106 cells/ml inHBSS (37°C)
with or without 1 mM CaC12. Cells were monodispersed and viability was
>95 %, as assessed by Trypan blue dye exclusion.
1-ml aliquots were transferred to wells in a 24-well tissue culture tray
(Costar Corp., Cambridge, MA) that had been previously incubated with
1% HSA in HBSS for at least 1 h and washed thoroughly with HBSS im-
mediately before use. This treatment prevents nonspecific cell sticking to
the tissue culture dish (Tàkeichi, 1977). The tissue culture trays containing
the suspended L cells were rotated on a gyratory shaker (90 rpm) at 37°C.
At desired intervals, aggregation was stopped by additionof glutaraldehyde
to a final concentration of 2%.
Aggregation was quantified by examining representative aliquotsof equal
volumes from each sample on a hemacytometer grid under phase contrast
optics. The number of cells remaining as single cells or present in ag-
gregates (>three cells) were counted innine squares. At least 800cells were
counted for each sample. Data are expressed as the percent of total cells
present in aggregates.
Results
Nucleotide Sequence andMessageSize ofPECAM1
To more fully characterize the structure and function of
PECAM-1 and to prepare a full-length expression construct,
its nucleotide sequence was determined from two overlap-
ping clones. As shown in Fig. 1, the 2,557-bp sequence con-
tains a 141-bp 5' untranslated (UT) region, an open reading
frame of 2,214 by that encodes 738 amino acids (AA), and
a 202-bp 3' UT region. The ensuing 3' UT region has appar-
ently been only partially determined, since Northern blot
analysis (Fig. 2) indicates that the full-length mRNA from
either HEL cells or endothelial cells was -4.2 kb. A smaller
mRNA species at -3.8 kb was also consistantly observed un-
der high stringency hybridization and wash conditions, how-
ever its significance is as yet unknown.
Expression ofPECAM1 in COS-7and 3T3Cells
To gain insight into the nature of PECAM-mediated cellular
recognition events and to confirm the validity of our cDNA
sequence, a full-length'PECAM-1 cDNA was cloned into the
expression vector pESP-SVTEXP and transfected into COS
and 3T3 cells.
PECAM-1 expression was demonstrated by immunopre-
cipitation of [35S]methionine-labeled extracts from trans-
fected cellsand human umbilical vein endothelial cells using
an anti-PECAM-1 monoclonal antibody (Fig. 3, top) . Pro-
tein bands at 130 and 120 kD were detected in transfected
3T3 cells (Fig. 3, lane B) and COS cells (Fig. 3, lane C) that
behaved identically to the material immunoprecipitated from
control endothelial cells (Fig. 3, lane A). The lower band
likely represents a precursor protein as it was not seen when
surface-labeled material was immunoprecipitated (see Fig.
3, E-G). No cross-reacting material of similar size was de-
tected in control 3T3 cells (Fig. 3, lane D). Since the cDNA
itself encodes a polypeptide core of only 80 kD (Newman
et al., 1990 and Fig. 1), these data suggest that the primary
sequence of recombinant PECAM-1 is sufficient to direct
normal or near-normal postiranslational processingin mon-
key kidney cells or murine fibroblasts.
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TACCAGTGTGTTGCAGATAATTGCCATTCCCATGCCAAAATGTTAAGTGAGGTTCTGAGGGTGAAGGTGATAGCCCCGGTGGATGAGGTCCAGATTTCTATCCTGTCAAGTAAGGTGGTG 1680
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ATGAAACCAATAAATGATAATAAAGAGCCTCTGAACTCAGACGTGCAGTACACGGAAGTTCAAGTGTCCTCAGCTGAGTCTCACAAAGATCTAGGAAAGAAGGACACAGAGACAGTGTAC 2280
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GCTAAGTTAATGTTGGGTAGAAAGAGATACAGAGGGG
￿
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Figure 1. Primary structure and nucleotide sequence of PECAM-1. The amino acid sequence is numbered from the first residue after the
predicted cleavage site ofthe 27-amino acid signal peptide. The hydrophobic putative signal peptide and transmembrane sequence are under-
lined. Two naturally occurring Ecolil sites are boxed. Cysteine residues thought to participate in disulfide bond formation within individual
immunoglobulin homology units are circled. The sequence containsnine potentialN-linked glycosylation sites, denoted by closed triangles,
and one potential tyrosine phosphorylation site at residue 686, indicated with a closed circle. The TAG stop codon is underlined and in
bold type. These sequence data are available from EMBL/GenBank/DDBJ under accession number M28526.
To determine if the protein was directed to the plasma
membrane of the transfected cells and to further confirm
the relationship of PECAM-1 to endoCAM and the CD31
antigen, extracts from 1251-surface-labeled PECAM-1 trans-
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fected or sham transfected COS-7cellswere immunoprecipi-
tated with an anti-endoCAM polyclonal antibody (Fig. 3 E),
an anti-CD31 mAb (Fig. 3 F), or an anti-PECAM-1 mono-
clonal antibody (Fig. 3 G). A MAD protein was clearly
1062Figure 2 . Northern blot analysis of
PECAM-1 . Tbtal cellular RNA was
isolated from human umbilical endo-
thelial cells, denatured with glyoxal,
and separated on a 1% agarose gel .
After transfer to nitrocellulose, the
blot was hybridized with a nick-trans-
lated PECAM-1 cDNA probe under
high-stringency conditions (see Ma-
terials and Methods) . Size markers
in kilobases are shown on the left .
Under these conditions, a major
RNA at 4.2 kb and a smaller band at
3 .8 kb are revealed .
identified on the surface of transfected COS-7 cells with all
three antibodies (arrow) confirming the identity of CD31,
PECAM-1, andendoCAM suggested earlier (Albelda et al.,
1990 ; Newman et al ., 1990) .
Transfected PECAM-1 Protein Is Concentrated at the
Intercellular Junctions ofAdjacent TMnsfected Cells
When human or bovine endothelial cells were stained with
anti-PECAM-1 or endoCAM antibodies, a striking localiza-
tion to cell-cell borders was observed (Muller et al ., 1989 ;
Albelda et al ., 1990) . It was therefore necessary to examine
the cellular localization ofPECAM-1 in the transfected cells .
To accomplish this, COS-7 cells, transfected with PECAM-1,
were plated onto glass coverslips . After 48 h, the cells were
fixed, permeabilized, and stained with anti-PECAM-1 mAb
followed by a secondary FITC-labeled anti-mouse antibody.
In individual transfected cells that were not in contact with
other transfected cells, a bright, diffuse pattern of fluores-
cence was observed (data not shown) . In contrast, when
transfected cells were in contact with other transfected cells,
the PECAM-1 antigen localized to cell-cell borders (Fig .
4B) in a manner very similar to endothelial cells (Fig . 4 A) .
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Figure 3 . Expression of PECAM4 in COS-7 and 3T3 cells . (Top)
Nonionic detergent extracts from cells metabolically labeled with
[ 35S]methionine were immunoprecipitated with an anti-PECAM-1
mAb . Lane A, human umbilical vein endothelial cells ; lane B,
PECAM-1-transfected 3T3 cells ; lane C, PECAM-1 transfected
COS-7 cells ; lane D, neomycin-transfected 3T3 cells . Transfected
cells expressed 130- and 120-kD proteins (arrow) similar in size
to those expressed by human umbilical vein endothelial cells. (Bot-
tom) Extracts from 115I-surface-labeled COS-7 cells that had been
transfected with PECAM4 cDNA (+) or sham transfected (-)
were immunoprecipitated with three different antibodies. Lanes E,
anti-bovine endoCAM polyclonal antiserum ; lanes F, anti-CD31
mAb ; lanes G, hec7, an anti-human PECAM-1 mAb . A 130-kD
protein (arrow) was recognized in transfected cells by all three anti-
bodies confirming the relationship among these molecules . Molec-
ular weight markers in kilodaltons are shown on the left.
When a transfected cell contacted a nontransfected cell (Fig.
4 B, arrowheads), there was no cell-cell localization, despite
the fact that the same transfected cell did localize PECAM-i
to the cell-cell border of an adjacent transfected cell .
To determine if transfectedPECAM-1 protein was able to
interact with its natural counterreceptor on human endo-
thelial cells, PECAM-1 transfected 3T3 cells were co-cultured
withhuman umbilical vein cells . Fig . 5 shows a double-label
immunofluorescence experiment in which PECAM-1 expres-
sion was detected using an mAb (Fig . 5 A) and the endothe-
lial cells within the culture were identified using a polyclonal
1063Figure 4. Transfected PECAM-1 protein concentrates at the inter-
cellular junctions of adjacently transfected COS-7 cells . Human
umbilical vein endothelial cells (A) orPECAM-1 transfected COS-7
cells (B) were fixed, permeabilized, and stained with an anti-
PECAM-1 mAb followed by a secondary FITC-labeled anti-mouse
antibody. The endothelial cells show the characteristic concentra-
tion of protein at intercellular borders (A) . Adjacent transfected
cells show a similar pattern of intercellular staining (B) . In con-
trast, when non-transfected cells (arrows) contact transfected cells,
there is no localization ofPECAM-1 protein at the cell-cell border .
These findings suggest that PECAM-1 functions in a homophilic
manner.
rabbit antiserum specific for VWF that is not expressed by
the 3T3 cells in the same culture (Fig . 5 B) . The VWF-posi-
tive endothelial cells (Fig. 5 B, arrows) were readily distin-
guishable from the transfected 3T3 cells (Fig . 5 B, arrow-
heads) . PECAM-1 is seen concentrated between apposing
endothelial cells (Fig . 5 A, solidarrowhead) and apposing
transfected 3T3 cells (Fig. 5 A, open arrowhead) . In addi-
tion, PECAM-1 can be found localized at points ofcontact be-
tween the endothelial cells and transfected 3173 cells (Fig . 5 A,
arrow) . No such localization of PECAM-1 was seen at the
junction of non-transfected 3T3 cells andhuman endothelial
cells (data not shown) . Thus, transfected PECAM-1 appears
to recognize its ligand on endothelial cells in the same man-
ner as endogenous endothelial PECAM-1 .
PECAM-1 Mediates theAggregation
of 71ransfectedL Cells
To directly evaluate the ability ofPECAM-1 to mediate adhe-
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sion, cell aggregation studies were performed . Mouse L cell
fibroblasts do not spontaneously aggregate with each other
(Takeichi, 1977) . However, L cells expressing adhesion mol-
ecules such as variouscadherins (Noseet al ., 1988) orCD44
(St . John et al ., 1990) have been shown to aggregate specifi-
cally. To use this system to test whetherPECAM-1 was capa-
ble of mediating cell-cell adhesion, we stably transfected L
cells withPECAM cDNA that had been inserted into our eu-
karyotic expression vector, pESF-SVTEXP FACS analysis
showed that 65% of the transfected L cells expressed sig-
nificant amounts of the protein on their surfaces (Fig. 6 b) .
Non-enzymatically resuspended L cells expressingPECAM-1
rapidly formed aggregates composed of three to several
dozen cells (Fig . 6 d) while cells transfected with the neomy-
cin gene only did not (Fig. 6 c) . Distinct aggregation was evi-
dent within 5 min (data not shown) and nearly maximal lev-
els were achieved by 15 min (Fig . 6 a) . Cell viability was
essentially unchanged over the course of the assay. The ag-
gregation of the PECAM-1 transfectants required the pres-
ence of calcium . The rate and extent of aggregation of the
PECAM-1 transfectants was similar to those reported for L
cells transfected with the other adhesion molecules cited
above .
The specificity ofthe aggregation reaction was tested using
a polyclonal antibody prepared against purified human
PECAM-1 (Fig . 7) . This reagent reacted only with PECAM-1
as assessed by immunoprecipitation of [35S]methionine-la-
beled cells (Fig . 7) . The polyclonal antiserum reacted with
the same material in extracts of endothelial cells as did the
anti-PECAM mAb (Fig . 7, A and C) . No reactivity was
noted with preimmune serum from the same rabbit (Fig .
7B) . Similarly, the polyclonal anti-PECAM-1 antiserum im-
munoprecipitated a doublet of the same relative molecular
mass from the transfected L cells used in the aggregation as-
say (Fig . 7 E) . This protein was not detected in nontrans-
fected L cells (Fig. 7 G) . No material was immunoprecipi-
tated from transfected (Fig . 7 D) or nontransfected L cells
(Fig. 7 F) with preimmune serum .
Fig . 8 demonstrates the effect ofthis antibody onPECAM-
1 mediated L cell aggregation . As noted in Fig. 6, only cells
transfected with the vector carrying PECAM-1 participated
in aggregate formation which was complete by 30 min . Ex-
posure ofcells to the polyclonalPECAM-1 antibody reduced
aggregation to the background levels noted with cells trans-
fected with the neomycin vector alone (Fig . 8) . Thus, the
aggregation noted in transfected L cells is directly mediated
by PECAM-1 expressed on the surface of these cells .
Discussion
The ability ofcirculating blood cells to adhere toone another
and to the vascular endothelium is a highly regulated process
fundamental to immunity, inflammation and thrombosis.
These cell-cell interactions are mediated by a variety of
specific adhesion molecules (reviewed by Butcher, 1989 ;
Albelda and Buck, 1990; Carlos and Harlan, 1990 ; and
Springer, 1990) . Information about these molecules and the
mechanisms of their adhesive interactions is critical to an
understanding of the processes in which they are involved .
PECAM-1 (CD31) is the newest ofthe vascular cell adhesion
molecules to be reported .
1064ThecDNA sequence ofPECAM-1 contains two eukaryotic
initiation (AUG) codons in the 5' untranslated region, one
beginning at base 95 and the other at nucleotide 142 . Being
largely devoid to T residues and having a purine at the -3
position, both of these codons are flanked by nucleotides
that would permit functional initiation of protein synthesis
according to the consensus sequence established by Kozak
(1987) . Fewer than 10% ofvertebratemRNAs contain multi-
ple upstream initiation codons, but ribosomes are known
to initiate exclusively at the 5' most ATG codon when it lies
in a favorable context (Kozak, 1987) . Interestingly, upstream
codons that do lie within a Kozak sequence are almost always
followed by a termination codon ; such is the case for PECM4,
as the ATG at base 95 is followed by a TAA stop codon only
16 bases downstream . It is therefore likely that after the ter-
mination of translation ofthis 15-bp minicistron, ribosomes
reinitiate at base 142 and translate until the stop codon at
base 2355.
Recently, two other groups have reported the molecular
cloning of PECAM-1 (Stockinger et al ., 1990 ; Zehndar,
L . J., K . Hirai, J. L . McGregor, L . J. Levitt, and L . I . K .
Leung. 1990 . Blood (Suppl. 1) . 76:225a .) and noted several
minor discrepancies with our earlier published amino acid
sequence for this protein (Newman et al., 1990) . The vari-
ances noted by each of these groups were at different nucleo-
tides, suggesting that PECAM-1 may have several poly-
morphic forms within thehuman gene pool . Whether these
potentially allelic forms alter the function or specificity of
PECAM-1 mediated interactions is not yet known .
Transfection ofCOS, 3T3 or L cells with a eukaryotic ex-
pression vector containing PECAM-1 cDNA resulted in the
production and surface expression ofa 130-kD glycoprotein
(Fig . 3 A) . The ability ofthis protein to cross-react with anti-
PECAM-1 antibodies and the anti-CD31 mAb confirms the
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Figure 5 . Transfected PECAM-1 protein
can interact with native PECAM-1 protein
on human endothelial cells. 3T3 cells trans-
fected withPECAM-1 cDNA were co-plated
with human umbilical vein endothelial cells
and simultaneously stained with an anti-
PECAM-1 monoclonal antibody (A) and an
anti-von Willebrand's factor (vWF) poly-
clonal antiserum (B) . Identical fields con-
taining four cells are shown inA andB . The
cells were then treated with FITC-labeled
anti-mouse antibody (A) and rhodamine-
labeled anti-rabbit antibody (B), Four cells
can be visualized . The reactivity with vWF
antibody (B, solid arrows) demonstrates
that the two cells on the left are endothelial
cells and the two cells on the right are 3T3
cells (B, solid arrowheads) . PECAM-1 pro-
tein is localized to the intercellular borders
on the two endothelial cells (A, solidarrow-
head) and the two transfected 3T3 cells (A,
open arrowhead) . In addition, the proteinis
localized to the border of one of the endo-
thelial cells and a transfected 3T3 cell (A,
solid arrow), demonstrating that the trans-
fected protein functions in a similar manner
to the native endothelial cell protein .
identity of the expressed protein as PECAM-1 . In addition,
the reactivity of the transfected protein with the antibodies
against endoCAM, a similar molecule to PECAM-1 ex-
pressed in bovine cells, confirms that indeed, these two pro-
teins are homologous (Fig . 3 B) .
The experiments described in this report provide further
evidence that PECAM-1 functions as a cell-cell adhesion
protein . Analysis of the cellular distribution of the trans-
fected protein clearly shows that PECAM-I is concentrated
at the periphery of adjacent transfected COS and 3T3 cells
in a manner reminiscent of its distribution in endothelial
cells (Fig . 4) . When transfected cells contact nontransfected
cells, no cell-cell localization ofPECAM-1 occurs . The con-
centration of PECAM-1 at intercellular junctions of trans-
fected cells and endothelial cells when they are co-cultured
suggests that the protein in transfected cells can respond to
its natural ligand on adjacent endothelial cells . More direct
evidence that PECAM-1 functions 'as a cell-cell adhesion
protein is provided in experiments showing that the molecule
supports calcium-dependent cell-cell aggregation when ex-
pressed in mouse L cells (Fig . 6) and that this aggregation
can be inhibited by an anti-PECAM-1 antibody (Fig . 8) . A
similar assay has been used to demonstrate the ability of a
number of molecules, including N-CAM (Cunningham et
al ., 1987), cadherins (Takeichi, 1988 ; Nose et al., 1988),
and CD44 (St . John et al., 1989) to participate in cell-cell
adhesion .
Although the mechanism(s) whereby PECAM-1 partici-
pates in cell-cell adhesion is not yet clear, there are several
possibilities, the most obvious being homophilic binding in
which PECAM-1 on one cell binds to another molecule of
PECAM-1 on an adjacent cell . This possibility is suggested
by the finding that PECAM-1 localizes to cell-cell borders
only when a fibroblast transfected withPECAM-1 is in con-
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Figure 6. PECAM4 mediates the calcium-dependent aggregation
of transfected L cells. L cells transfected with PECAM-1 cDNA
(PECAM) or with the neomycin resistance gene only (Neo) were
nonenzymatically resuspended from tissue culture dishes, washed,
and incubated at 37°C under gentle agitation in thepresence (+ Ca)
or absence (-Ca) of 1 mM Cal' as described in Materials and
Methods . (a) The percentage of cells in aggregates was determined
as a function of time. The data from one representative experiment
is shown . Standard deviations are not indicated in the figure, but
were always< 5-10% . (b) ExpressionofPECAM-1 by transfectants
used for this figure was assessed by fluorescence activated cell sort-
ing using mAb he67. Open curve represents staining profile of
control (Neo) transfectants; shaded curve represents profile of
PECAM-1 transfectants . 65% of thetransfected L cells showed lev-
els of fluorescence greater than the control cells. Human umbilical
vein endothelial cells show a peak fluorescence of 45 on this scale .
(c) Appearance of L cells transfected with neomycin resistance
gene after 30 min in the presence of Caz+ . Arrows point to occa-
sional aggregates that are formed by control cells . (d) Appearance
of L cells transfected with PECAM-1 cDNA after 30 min in the
presence of Cal' . Extensive aggregation is seen . Bars, 100 am .
tact with another transfected cell (Fig . 4) or in contact with
a cell that normally expresses PECAM-1 on its surface such
as an endothelial cell (Fig . 5) . In addition, the expression of
PECAM-1 in normally nonaggregating L cells promotes
their self aggregation . The calcium dependence of this pro-
cess (Fig . 6), however, differs from the well-documented abil-
ity ofmembers of the immunoglobulin superfamily to medi-
ate homophilic aggregation in the absence of calcium . For
example, calcium-independent aggregation has been dem-
onstrated for N-CAM, myelin Po protein, Ll, Fasciclin 1,
Thy 1, CEA, and myelin-associated glycoprotein (Edelman,
1988 ; Filbin et al ., 1990 ; Rathjen and Schachner, 1984 ;
Elkins et al ., 1990 ; He et al., 1991; Benchimol et al., 1989 ;
Poltorak et al., 1987) .
In addition to its presence at the intercellular junctions of
cells that grow in monolayers (i.e ., endothelial cell and
transfected fibroblasts), PECAM-1 is also expressed on the
surface of cells that normally exist in suspension, including
peripheral blood monocytes, neutrophils, platelets, and cer-
tain T cell subsets . In this light, it is notable thatPECAM-1
mediated aggregation of transfectedL cells, which also grow
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Figure 7 . Polyclonal anti-PECAM-1 antibody specifically recog-
nizes PECAM-1 in human umbilical vein endothelial cells and L
cells transfected withPECAM-1 . Human umbilicalveinendothelial
cells (A-C),Lcellstransfected withPECAM-1 (Dand E), and non-
transfected L cells (F and G) were labeled metabolically with
[35S]methionine . Nonionic detergent extracts were then inimuno-
precipitated with anti-PECAM mAb (A), a 1:250 dilution of pre-
immune rabbit serum (B, D, and F) or a 1:250 dilution of anti-
PECAM-1 polyclonal antibody (C E, and G) . Both themAb and
the polyclonal antiserum identified the characteristic doublet at
130-120 kD in human endothelial cells. Preimmune serum was
nonreactive . In addition, the polyclonal anti-PECAM antiserum
identified PECAM protein in the transfected L cells used in the
aggregation assay but not in nontransfected L cells . No proteins
were detected in either cell line with preimmune serum . Molecular
weight markers in kilodaltons are shown on the left .
in suspension, was found to be calcium dependent (Fig . 6) .
This raises the interesting possibility that PECAM-1-medi-
ated cellular interactions may be heterophilic in certain cell
types, that is, PECAM-1 on one cell binds to a different mol-
ecule on the cell itcontacts . Consistent with this idea, a num-
ber of calcium dependent heterophilic interactions mediated
by members of the immunoglobulin superfamily have been
described . These include ICAM-1 and ICAM-2 binding to
ßz integrins (Staunton et al ., 1990), and VCAM-1 binding
to VLA-4, a ß, integrin (Elices et al., 1990) . Whether this
reflects the requirement for divalent cations of only the inte-
grin involved or also the immunoglobulin superfamily coun-
ter-receptor is not known . Recently, amouse carcinoembry-
onic antigen gene familymember(mmCDM2), also amember
of the immunoglobulin superfamily, was shown to require
calcium to permit aggregation (Turbide et al., 1991) . How-
ever, it was not determined if this represented a homophilic
or heterophilic interaction .
IfPECAM-1 participates in heterophilic binding, the ques-
tion arises as to the identity ofthe counter receptor. One pos-
sibility, as discussed above, is that it could be a member of
the integrin family. The presence of a consensus glycos-
aminoglycan recognition sequence in its extracellular domain
also raises the possibility that PECAM-1 binds to a proteo-
glycan expressed on an adjacent cell . This sequence, X-B-B-
X-B-X, whereB is a basic residue andX is a hydropathic res-
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Figure 8. Aggregation of PECAM-1 transfectants is selectively in-
hibited by anti-PECAM-1 antibody. L cells transfected with
PECAM-1 cDNA (PECAM) or with neomycin resistancegene only
(NEO) were nonenzymatically resuspended from tissue culture
dishes, washed, incubated in 25 gg/ml rabbit anti-PECAM-1 IgG
(ANTI-PECAMIgG) or the same concentration ofnonimmune rab-
bit IgG (CONTROL IgG) for 20 min at 4°C, washed again, and in-
cubated at 37°C under gentle agitation in the presence of 1 mM
Caz+, as described in Materials and Methods. Data points were
taken as for Fig. 6. The data are representative of many experi-
ments. Standard deviations were less than the dimensions of the
symbols on the graph.
idue, as described by Cardin and Weintraub (1989), is located
in a hydrophilic segment at the transition between proposed
fl-pleated sheet D and E in loop 2 of PECAM-1 (Newman
et al ., 1990) at amino acids 151-156 (LKREKN) . A similar
glycosaminoglycan recognition sequence is located in almost
the same place in loop 2 of the N-CAM molecule (Reyes et
al., 1990). In this case, N-CAM has been shown to interact
with heparan sulfate glycosaminoglycan (Coleet al., 1986).
Thus, it is possible that PECAM-1 could mediate hetero-
philic adhesive events either via proteoglycan or integrin
counter receptors.
The involvement of a second, different molecule such as
a proteoglycan does not necessarily indicate heterophilic
adhesion. It may be that the second molecule is required as
a cofactor. This mechanism has been evoked to explain the
heparan sulfate proteoglycan dependence of N-CAM (Cole
and Glaser, 1986; Cole et al., 1986; Reyes et al., 1990) and
Ll (Kadmon et al., 1990) mediated neural cell adhesion.
This mechanism, or a strictly heterophilic mechanism,
could function in the case of PECAM-1 mediated L cell
aggregation given the ubiquitous distribution on proteogly-
cans on cell surfaces.
The mechanisms whereby an immunoglobulin superfam-
ily molecule may promote intercellular adhesion are both
many and complex. At least one member ofthis superfamily,
Neural-glial CAM (Ng-CAM) can act as both a homophilic
and heterophilic receptor depending upon the type of cell
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with which it interacts (Grumet and Edelman, 1988). Given
that PECAM-1 is expressed on the surface of a wide variety
of cells, some of which are organized into tissues, such as
endothelial cells, and others ofwhich interact with different
cells only under specific conditions of inflammation or blood
clotting, it is possible that a different mechanism may be in-
volved depending upon the specific adhesive event. Regard-
less of the mechanism by which PECAM-1 promotes adhe-
sion, its presence in relatively large quantities on platelets,
leukocytes, and endothelial cells suggests that it may be im-
portant in a wide variety of vascular processes.
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